< 0 1 0 1 O
= 1 2 1 2 O
18 3 5 3 5 B-upper_bound
years 6 11 6 11 I-upper_bound
of 12 14 12 14 O
age 15 18 15 18 B-age

A 0 1 19 20 O
strong 2 8 21 27 B-treatment
or 9 11 28 30 I-treatment
moderate 12 20 31 39 I-treatment
CYP3A 21 26 40 45 I-treatment
inhibitor 27 36 46 55 I-treatment
or 37 39 56 58 I-treatment
inducer 40 47 59 66 I-treatment
within 48 54 67 73 O
7 55 56 74 75 B-upper_bound
days 57 61 76 80 I-upper_bound

An 0 2 81 83 O
excluded 3 11 84 92 O
antiplatelet 12 24 93 105 B-treatment
/ 24 25 105 106 O
anticoagulant 25 38 106 119 B-treatment
drug 39 43 120 124 I-treatment
or 44 46 125 127 O
a 47 48 128 129 O
herbal 49 55 130 136 B-treatment
supplement 56 66 137 147 I-treatment
that 67 71 148 152 O
affects 72 79 153 160 O
platelet 80 88 161 169 O
function 89 97 170 178 O
within 98 104 179 185 O
7 105 106 186 187 B-upper_bound
days 107 111 188 192 I-upper_bound
, 111 112 192 193 O
or 113 115 194 196 O
5 116 117 197 198 O
half 118 122 199 203 O
- 122 123 203 204 O
lives 123 128 204 209 O
, 128 129 209 210 O
whichever 130 139 211 220 O
is 140 142 221 223 O
longer 143 149 224 230 O

Aspirin 0 7 231 238 B-treatment
within 8 14 239 245 O
7 15 16 246 247 B-upper_bound
days 17 21 248 252 I-upper_bound
, 21 22 252 253 O
or 23 25 254 256 O
5 26 27 257 258 O
half 28 32 259 263 O
- 32 33 263 264 O
lives 33 38 264 269 O
, 38 39 269 270 O
whichever 40 49 271 280 O
is 50 52 281 283 O
longer 53 59 284 290 O

Eastern 0 7 291 298 B-clinical_variable
Cooperative 8 19 299 310 I-clinical_variable
Oncology 20 28 311 319 I-clinical_variable
Group 29 34 320 325 I-clinical_variable
( 35 36 326 327 I-clinical_variable
ECOG 36 40 327 331 I-clinical_variable
) 40 41 331 332 I-clinical_variable
less 42 46 333 337 O
than 47 51 338 342 O
3 52 53 343 344 B-upper_bound

Hydroxyurea 0 11 345 356 B-treatment
that 12 16 357 361 O
is 17 19 362 364 O
ongoing 20 27 365 372 O
( 28 29 373 374 O
hydroxyurea 29 40 374 385 B-treatment
is 41 43 386 388 O
permitted 44 53 389 398 O
up 54 56 399 401 O
to 57 59 402 404 O
the 60 63 405 408 O
first 64 69 409 414 O
dose 70 74 415 419 O
) 74 75 419 420 O

Inotuzumab 0 10 421 431 B-treatment
within 11 17 432 438 O
30 18 20 439 441 B-upper_bound
days 21 25 442 446 I-upper_bound
and 26 29 447 450 O
must 30 34 451 455 O
have 35 39 456 460 O
ALT 40 43 461 464 B-clinical_variable
, 43 44 464 465 O
AST 45 48 466 469 B-clinical_variable
and 49 52 470 473 O
bilirubin 53 62 474 483 B-clinical_variable
< 63 64 484 485 O
ULN 65 68 486 489 O

Karnofsky 0 9 490 499 B-clinical_variable
greater 10 17 500 507 O
than 18 22 508 512 O
or 23 25 513 515 O
equal 26 31 516 521 O
to 32 34 522 524 O
50 35 37 525 527 B-lower_bound

Lansky 0 6 528 534 B-clinical_variable
greater 7 14 535 542 O
than 15 19 543 547 O
or 20 22 548 550 O
equal 23 28 551 556 O
to 29 31 557 559 O
50 32 34 560 562 B-lower_bound

Must 0 4 563 567 O
have 5 9 568 572 O
relapsed 10 18 573 581 O
or 19 21 582 584 O
refractory 22 32 585 595 O
acute 33 38 596 601 B-cancer
lymphoblastic 39 52 602 615 I-cancer
leukemia 53 61 616 624 I-cancer
( 62 63 625 626 I-cancer
ALL 63 66 626 629 I-cancer
) 66 67 629 630 I-cancer
or 68 70 631 633 O
relapsed 71 79 634 642 O
or 80 82 643 645 O
refractory 83 93 646 656 O
lymphoblastic 94 107 657 670 B-cancer
lymphoma 108 116 671 679 I-cancer
( 117 118 680 681 I-cancer
LL 118 120 681 683 I-cancer
) 120 121 683 684 I-cancer

Participant 0 11 685 696 O
has 12 15 697 700 O
central 16 23 701 708 B-chronic_disease
nervous 24 31 709 716 I-chronic_disease
system 32 38 717 723 I-chronic_disease
( 39 40 724 725 I-chronic_disease
CNS 40 43 725 728 I-chronic_disease
) 43 44 728 729 I-chronic_disease
disease 45 52 730 737 I-chronic_disease
with 53 57 738 742 O
cranial 58 65 743 750 O
involvement 66 77 751 762 O
that 78 82 763 767 O
requires 83 91 768 776 O
radiation 92 101 777 786 B-treatment

Participants 0 12 787 799 O
on 13 15 800 802 O
venetoclax 16 26 803 813 B-treatment
at 27 29 814 816 O
screening 30 39 817 826 O
may 40 43 827 830 O
enroll 44 50 831 837 O
and 51 54 838 841 O
remain 55 61 842 848 O
on 62 64 849 851 O
venetoclax 65 75 852 862 O

Participants 0 12 863 875 O
with 13 17 876 880 O
malabsorption 18 31 881 894 B-chronic_disease
syndrome 32 40 895 903 I-chronic_disease
or 41 43 904 906 O
any 44 47 907 910 O
other 48 53 911 916 O
condition 54 63 917 926 O
that 64 68 927 931 O
precludes 69 78 932 941 O
enteral 79 86 942 949 O
administration 87 101 950 964 O

Philadelphia 0 12 965 977 B-cancer
Chromosome 13 23 978 988 I-cancer
( 24 25 989 990 I-cancer
Ph)+ 25 29 990 994 I-cancer
ALL 30 33 995 998 I-cancer
subjects 34 42 999 1007 O
on 43 45 1008 1010 O
TKIs 46 50 1011 1015 B-treatment
at 51 53 1016 1018 O
Screening 54 63 1019 1028 O
may 64 67 1029 1032 O
enroll 68 74 1033 1039 O
and 75 78 1040 1043 O
remain 79 85 1044 1050 O
on 86 88 1051 1053 O
Tyrosine 89 97 1054 1062 B-treatment
Kinase 98 104 1063 1069 I-treatment
Inhibitor 105 114 1070 1079 I-treatment
( 115 116 1080 1081 I-treatment
TKI 116 119 1081 1084 I-treatment
) 119 120 1084 1085 I-treatment
therapy 121 128 1086 1093 I-treatment
to 129 131 1094 1096 O
control 132 139 1097 1104 O
disease 140 147 1105 1112 O

Refractory 0 10 1113 1123 O
is 11 13 1124 1126 O
defined 14 21 1127 1134 O
as 22 24 1135 1137 O
persistent 25 35 1138 1148 O
disease 36 43 1149 1156 O
after 44 49 1157 1162 O
at 50 52 1163 1165 O
least 53 58 1166 1171 O
2 59 60 1172 1173 B-lower_bound
courses 61 68 1174 1181 O
of 69 71 1182 1184 O
chemotherapy 72 84 1185 1197 B-treatment

Steroid 0 7 1198 1205 B-treatment
therapy 8 15 1206 1213 I-treatment
for 16 19 1214 1217 O
anti 20 24 1218 1222 O
- 24 25 1222 1223 O
neoplastic 25 35 1223 1233 O
intent 36 42 1234 1240 O
within 43 49 1241 1247 O
5 50 51 1248 1249 B-upper_bound
days 52 56 1250 1254 I-upper_bound

greater 0 7 1255 1262 O
than 8 12 1263 1267 O
16 13 15 1268 1270 B-lower_bound
years 16 21 1271 1276 I-lower_bound
of 22 24 1277 1279 O
age 25 28 1280 1283 B-age

have 0 4 1284 1288 O
adequate 5 13 1289 1297 O
performance 14 25 1298 1309 B-clinical_variable
status 26 32 1310 1316 I-clinical_variable

less 0 4 1317 1321 O
than 5 9 1322 1326 O
or 10 12 1327 1329 O
equal 13 18 1330 1335 O
to 19 21 1336 1338 O
16 22 24 1339 1341 B-upper_bound
years 25 30 1342 1347 I-upper_bound
of 31 33 1348 1350 O
age 34 37 1351 1354 B-age

weigh 0 5 1355 1360 B-clinical_variable
greater 6 13 1361 1368 O
than 14 18 1369 1373 O
or 19 21 1374 1376 O
equal 22 27 1377 1382 O
to 28 30 1383 1385 O
20 31 33 1386 1388 B-lower_bound
kg 34 36 1389 1391 I-lower_bound

